CelLBxHealth plc (AIM:CLBX)
1.100
0.00 (0.00%)
At close: Dec 31, 2025
CelLBxHealth Revenue
CelLBxHealth had revenue of 796.00K GBP in the half year ending June 30, 2025, a decrease of -33.44%. This brings the company's revenue in the last twelve months to 2.62M, up 29.64% year-over-year. In the year 2024, CelLBxHealth had annual revenue of 2.86M with 30.92% growth.
Revenue (ttm)
2.62M
Revenue Growth
+29.64%
P/S Ratio
4.76
Revenue / Employee
22.05K
Employees
119
Market Cap
12.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.86M | 676.00K | 30.92% |
| Dec 31, 2023 | 2.19M | 1.15M | 109.99% |
| Dec 31, 2022 | 1.04M | 28.00K | 2.76% |
| Dec 31, 2021 | 1.01M | 251.00K | 32.94% |
| Dec 31, 2020 | 762.00K | -109.50K | -12.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |
CelLBxHealth News
- 4 weeks ago - CelLBxHealth plc (ANPCY) Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation Transcript - Seeking Alpha
- 2 months ago - CelLBxHealth PLC Presents Proof-of-Concept Study - Accesswire
- 2 months ago - Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding - Accesswire
- 2 months ago - ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor - Accesswire
- 3 months ago - Angle PLC Announces Strategy Update - Accesswire
- 3 months ago - Angle PLC Announces Presentation of Data on Glioblastoma - Accesswire
- 3 months ago - Angle PLC Announces Board Changes - Accesswire
- 4 months ago - ANGLE Plc ADR (ANPCY) Q2 2025 Earnings Call Transcript - Seeking Alpha